Mylan's Acquisition of Matrix

Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

To download Mylan's Acquisition of Matrix case study (Case Code: BSTR279) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies


Buy With PayPal

Amount to be paid:

Prefer to pay in another currency ?
Select Currency for Payment

Exchange Rates: Click Here
Delivery Details: Click Here

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search

Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:


Case Code : BSTR279 For delivery in electronic format: Rs. 400;
For delivery through courier (within India): Rs. 400 + Shipping & Handling Charges extra


Mergers | Acquisitions | Strategic Alliances | Growth Strategy
Case Length : 20 Pages
Period : 2005-2007
Pub Date : 2008
Teaching Note : Not Available
Organization : Mylan, Inc., Matrix Laboratories Ltd.
Industry : Pharma and Biotech
Countries : USA; India; Global


In January 2007, Mylan Inc. (Mylan), one of the largest US generic drug makers, acquired a 71.5 percent stake in Matrix Laboratories Ltd. (Matrix), India, a leading Active Pharmaceutical Ingredients (API) supplier globally, for a cash and stock deal of US$736 million. The Mylan-Matrix deal was the largest acquisition in the Indian pharmaceutical industry and was viewed by analysts as a step toward backward integration for Mylan. The deal not only gave Mylan access to a low cost manufacturing platform, but also immediate presence in the emerging markets of Asia and Africa as well as the lucrative generic drugs markets in Europe.

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Matrix, on the other hand, gained the much-needed scale that generic companies required to survive in a very competitive market place. It was very important for Indian pharmaceutical companies considering that these companies did not have research molecules of their own.

Analysts felt that with the global generic drugs industry undergoing a consolidation phase, large pharmaceutical companies were eyeing Indian pharmaceutical companies as potential targets of M&A deals. This was because, with considerable pricing pressures in the US, these companies were on the lookout for low-cost suppliers.

In addition to the low-cost manufacturing platform, the attractiveness of the Indian companies stemmed from the fact that they had large and varied product portfolios and world-class manufacturing facilities. Indian pharmaceutical companies also had a number of Drug Master Files (DMFs) and Abbreviated New Drug Application (ANDA) filings in the US, the world's largest market for pharmaceuticals. Moreover, some of these companies had developed a significant presence in the European and African markets through the inorganic route.


Understand the issues and challenges in the global generic dugs industry, with special reference to the pharmaceutical market in the US and India.

Understand the reasons behind an the US-based Mylan, Inc.'s foray into the global market, in the backdrop of the challenges it faced in the US market.

Understand the issues and challenges faced by an Indian pharmaceutical company in growing its business in the international market.

Understand and appreciate the role of mergers and acquisitions as a growth strategy.


  Page No.
Benefits Beyond Global Expansion 1
Background Note 3
The Deal 6
Rationale behind the Acquisition 7
The Other View 9
Post Deal Developments 10
Outlook 11
Exhibits 12


Strategy, Competition, Merger & acquisition, Global expansion, Growth, Product portfolio, Supply chain, Backward integration, Generic drugs industry, Contract manufacturing, Pharmaceutical, Management, Restructuring, Mylan, Matrix, Teva, Sandoz, Barr, Actavis, E Merck, India, Low cost

Benefits Beyond Global Expansion - Next Page>>

Custom Search

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection


Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.